Dec 28 2007
Nanotechnology revolutionising medical sector in India
Dec 28: The concept of nanotechnology has a tremendous influence in various fields. The impact of which is now being felt in the medical sector. The extended possibility of nanotechnology allows the companies to develop better quality drugs. This technology is expected to captivate the medial world, the trend of miniature drugs will soon be a catch phrase in the market.
Drug researches are focussing their attention to discover unbelievably minute drugs that will be millionth of a millimetre or less to help in identifying diseases, enabling affordable treatments using targeted and effective medicine.
In India Dabur company put forth the nanotechnology based delivery system in the form of onco drug Nanoxel early this year that has created a sizeable impact. Now it is the turn of Biocon India’s leading drug manufacturing company as it is planning to launch Abraxane, a nanoparticle-based taxane to prove their presence in the surging field of nanotechnology. As the next initiative Biocon will launch a nanodrug named Abraxane that could cure breast cancer, in early 2008. Bharat Biotech is another company that is planning to exploit the scope of this innovative technology.
While commenting on this the CMD of Biocon Ltd, Ms Kiran Mazumdar Shaw said: “Nanodrugs are the need of the hour and it adds more value to the drug delivery system. It is playing a prominent role in life cycle management of the available drugs the entry of this technology has revolutionised the concept of drugs and it also encourage bioavailability and efficiency to a greater extent.”
In the near future we will see brand new nanodrugs that act as a remedy for problems related to skin implants, knee joints, valves, silver gels, tissue repair patches and lot more ailments.
